 |
bortezomib |
|---|---|
| Trade Name | Velcade |
| Orphan Indication | Neurofibromatosis type 2 |
| USA Market Approval | USA |
| USA Designation Date | 2016-07-05 00:00:00 |
| Sponsor | BioXcel Corporation;780 East Main Street, Suite 2;Branford, Connecticut, 06405 |
| |
bortezomib |
|---|---|
| Trade Name | Velcade |
| Orphan Indication | Neurofibromatosis type 2 |
| USA Market Approval | USA |
| USA Designation Date | 2016-07-05 00:00:00 |
| Sponsor | BioXcel Corporation;780 East Main Street, Suite 2;Branford, Connecticut, 06405 |